Dilevalol

Known as: Labetalol, (R,R)-Isomer, R,R Labetalol, R,R-Labetalol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1998
Review
1998
Essential hypertension is, at least in many subjects, associated with a decrease in insulin sensitivity, whereas glycemic control… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
1991
Review
1991
Dilevalol and labetalol are examples of a growing number of new beta-blockers which combine nonselective beta-adrenoceptor… (More)
Is this relevant?
1990
1990
Dilevalol, the R-R1 isomer of labetalol, has been shown in animal studies to be a non-selective beta-adrenoceptor antagonist with… (More)
Is this relevant?
1989
1989
We compared dilevalol (an isomer of labetalol), 200-400 mg daily, against atenolol, 50-100 mg daily, in a double-blind, crossover… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1989
1989
Renal function was measured in a total of 35 volunteers and patients who were given dilevalol, the R,R optical isomer of… (More)
Is this relevant?
1989
1989
Dilevalol (R,R'-isomer of labetalol) is an antihypertensive agent combining non-specific beta blockade with peripheral… (More)
Is this relevant?
1989
1989
The pharmacokinetics and pharmacodynamics of dilevalol, the R,R stereoisomer of labetalol, were evaluated in nine subjects… (More)
Is this relevant?
Review
1989
Review
1989
Dilevalol is the R-R' optical isomer of labetalol and differs pharmacologically from the racemic mixture in the following ways… (More)
Is this relevant?
1987
1987
Dilevalol, an alpha- and beta-blocking agent, has been evaluated in two patients with pheochromocytoma. Dilevalol could be a… (More)
Is this relevant?
1985
1985
The potency and selectivity of the intrinsic beta-sympathomimetic activity (ISA) of dilevalol were studied with isolated guinea… (More)
Is this relevant?